Pediatric influenza prevention and control

Nicola Principi1, Susanna Esposito

  • 1Institute of Pediatrics, University of Milan, Milan, Italy. nicola.principi@unimi.it

Insights

Global influenza vaccination rates in children are low, with high-risk children often unvaccinated. Increased efforts are crucial to protect vulnerable pediatric populations and encourage broader vaccination.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • Current influenza vaccination recommendations for children are not consistently followed globally.
  • A significant gap exists in vaccinating high-risk pediatric populations against influenza.
  • Influenza poses substantial risks, including complications, particularly for young children.

Purpose of the Study:

  • To evaluate global adherence to pediatric influenza vaccination guidelines.
  • To identify key populations for enhanced influenza vaccination efforts.
  • To highlight areas for improvement in pediatric influenza immunization strategies.

Main Methods:

  • Global assessment of current influenza vaccination practices in children.
  • Analysis of vaccination coverage among high-risk pediatric groups.
  • Review of recommendations for healthy infants and children with specific conditions.

Main Results:

  • Most children at high risk for influenza complications are not receiving the vaccine.
  • Vaccination of healthy infants (6-23 months) and their contacts is underutilized.
  • Vaccination is recommended for children with recurrent otitis media or respiratory infections, and potentially for healthy daycare/school-aged children.

Conclusions:

  • Urgent need for increased efforts to improve pediatric influenza vaccination rates, especially for high-risk groups.
  • Strong encouragement for vaccinating healthy infants and their close contacts is warranted.
  • Addressing physician and parent education, vaccine cost-effectiveness, safety, supply, and intranasal product availability is essential for optimizing influenza prevention in children.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...